Bruker Corporation to Participate in the 2021 Jefferies London Healthcare Conference
09 November 2021 - 11:00PM
Business Wire
Bruker Corporation (Nasdaq: BRKR) announced today it will
participate in the 2021 Jefferies London Healthcare Conference.
Gerald Herman, Executive Vice President & Chief Financial
Officer will participate in an analyst-moderated question and
answer session on behalf of the Company on Tuesday, November 16,
2021 at 12:20 PM GMT.
A live audio webcast of the question and answer session will be
available on the Investor Relations section of the Company's
website at https://ir.bruker.com. A replay will be posted in the
“Events & Presentations” section of the Bruker Corporation
Investor Relations website after the event and will be available
for 30 days.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high performance scientific instruments and high
value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular and cell biology research, in applied and pharma
applications, in microscopy and nanoanalysis, as well as in
industrial applications. Bruker offers differentiated, high-value
life science and diagnostics systems and solutions in preclinical
imaging, clinical phenomics research, proteomics and multiomics,
spatial and single-cell biology, functional structural and
condensate biology, as well as in clinical microbiology and
molecular diagnostics. For more information, please visit:
www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211109005441/en/
Investor Relations Bruker Corporation T: +1 (978) 663–3660, ext.
1479 E: Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Oct 2023 to Oct 2024